A A Silver
Overview
Explore the profile of A A Silver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Cicci R, de Hirsch K, Rabinovitch R, Saunders R, Hagin R, Silver A, et al.
Ann Dyslexia
. 2013 Nov;
37(1):1-9.
PMID: 24234983
No abstract available.
3.
Shytle R, Silver A, Lukas R, Newman M, Sheehan D, Sanberg P
Mol Psychiatry
. 2002 Jul;
7(6):525-35.
PMID: 12140772
While the monoamine deficiency hypothesis of depression is still most commonly used to explain the actions of antidepressant drugs, a growing body of evidence has accumulated that is not adequately...
4.
Shytle R, Penny E, Silver A, Goldman J, Sanberg P
J Hum Hypertens
. 2002 Jun;
16(7):453-7.
PMID: 12080428
Mecamylamine (Inversine), the first orally available antihypertensive agent, is now rarely used. Although celebrated in the 1950s, mecamylamine fell out of favour because of its widespread ganglionic side effects at...
5.
Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study
Silver A, Shytle R, Philipp M, Wilkinson B, McConville B, Sanberg P
J Clin Psychiatry
. 2001 Oct;
62(9):707-14.
PMID: 11681767
Background: Preclinical animal and open-trial clinical trials using nicotine gum and the transdermal nicotine patch found that treatment with nicotine potentiates the effects of neuroleptics in reducing the dyskinetic symptoms...
6.
Silver A, Shytle R, Sheehan K, Sheehan D, Ramos A, Sanberg P
J Am Acad Child Adolesc Psychiatry
. 2001 Sep;
40(9):1103-10.
PMID: 11556635
Objective: The safety and efficacy of mecamylamine as a monotherapy in children and adolescents with Tourette's disorder (TD) was investigated in an 8-week multicenter, double-blind, placebo-controlled study. Method: Eligible subjects...
7.
Shytle R, Silver A, Sanberg P
Biol Psychiatry
. 2000 Nov;
48(10):1028-31.
PMID: 11082479
Background: We have previously proposed that the therapeutic effect of transdermal nicotine in Tourette's syndrome may involve nicotinic receptor inactivation resulting from a prolonged continuous exposure to nicotine. In vitro...
8.
Silver A, Shytle R, Sanberg P
J Child Adolesc Psychopharmacol
. 2000 Aug;
10(2):59-68.
PMID: 10933116
Objective: To test the efficacy and safety of a nicotinic, acetylcholine antagonist, mecamylamine, in the treatment of Tourette's syndrome (TS). Methods: This is a retrospective, open-label study of 24 patients;...
9.
Sanberg P, Shytle R, Silver A
Lancet
. 1998 Sep;
352(9129):705-6.
PMID: 9728992
No abstract available.
10.
Sanberg P, Silver A, Shytle R, Philipp M, Cahill D, Fogelson H, et al.
Pharmacol Ther
. 1997 Jan;
74(1):21-5.
PMID: 9336013
Recent evidence has demonstrated that nicotine may obtund the symptoms of Tourette's syndrome (TS). TS is a neuropsychiatric disorder characterized by motor and vocal tics, obsessions and compulsions, and frequently...